A Study to Evaluate the Safety and Performance of TruGamma System for Tricuspid Replacement

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 180 participants.

Also called NCT07691307

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 180 participants (planned count) (from the registry)
Sponsor
Jiangsu Trulive Medical Co., Ltd (from the registry)
Registry
  • NCT NCT07691307
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07691307. Randomized; no masking; primary purpose treatment. Start 2026-03-18 (actual); primary completion 2028-08-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study to Evaluate the Safety and Performance of TruGamma System for Tricuspid Replacement
Condition
Tricuspid Valve Regurgitation
Condition
Tricuspid Valve Insufficiency
Condition
Tricuspid Valve Disease
Intervention (Device)
TruGamma System
Intervention (Drug)
Optimal medical therapy (OMT)
Lead sponsor
Jiangsu Trulive Medical Co., Ltd (class: other)

Record details

Record id
cardio:ct-nct07691307
Content hash
e48de7c1ad774b0063deb9373300f68a47f968668911a8ce8fbc911ee5cc885c